October 27, 2025
The work of the Harm-Benefit Task force was presented by Anton Bespalov at the FIN3R Center symposium in Turku (Finland). Copy of the presentation “Striking a Balance:
A Proposed Benefit Assessment Matrix for Ethical Animal Research“ is available from the OSF repository (link: https://osf.io/9cs3u/files/63x8m)
October 3, 2025
Anton Bespalov gave a lecture entitled “Drug discovery today: How to bet on the right horse?” at the Yerevan State University (Armenia)
September 11, 2025
Anton Bespalov participated in an online Open Science workshop organized by the Vilnius University (Lithuania). The purpose of this workshop is to educate around open science, to increase utilization of already available resources and tools, to increase scientific impact of work being done by inspiring to release tools and instruments created as open-source tools/instruments and increase sharing of data sets to the scientific community. Anton’s presentation was on “Assessing quality of research practice: Traceable and transparent experimental recordsAssessing quality of research practice: Traceable and transparent experimental records“
June 3, 2025
The work of the Harm-Benefit Task force was presented by Javier Guillen (Pamplona, Spain) and Penny Reynolds (Gainesville, FL, United States) at the 16th FELASA Congress in Athens (Greece) during the symposium “Harm-Benefit Analysis: A Tool for the Assessment of Benefit“
April 8, 2025
Anton Bespalov presented a webinar “Rigor in preclinical drug discovery research: Why not?” for the VICT3R consortium. This webinar took a critical look at the origins and consequences of low rigor in preclinical studies and dived into practical barriers that prevent or slow down the adoption of essential practices like randomization and blinding. With experience spanning PAASP, EQIPD, and the ECNP Preclinical Data Forum, Anton brought insights on what’s at stake and what needs to change.
Nov 16, 2023
Björn Gerlach presented the webinar “Enhancing Quality in Preclinical Data – EQIPD”, hosted by the FC3R initiative.
Sep 4, 2020
Martin Michel, CBO of PAASP GmbH, presents on the IMI project EQIPD, ALCOA principles, ALCOA-Plus, and FAIR principles.
Jul 7, 2020
An introduction on the reproducibility, biases and reporting. Presented by Martin Michel, CBO of PAASP GmbH, and streamed live at the University of Cologne.
Nov 16, 2016
Presented by Martin Michel, CBO of PAASP GmbH
Streamed live in the Cohen Veterans Bioscience Webinar series
A large fraction of published non-clinical research findings in the life sciences turns out to be non-reproducible. This wastes resources in research and undermines public trust in science, potentially putting public funding of such research in danger. The webinar will discuss the main reasons for lack of reproducibility with emphasis on inappropriate use of statistical approaches.